DiagnoCure names executive to head R&D

Quebec City, QC – Diagnostic test developer DiagnoCure says it has recruited Dr Timothy J Holzer from the US to head its research and development program.

“We are very pleased with this exceptional addition to our team – Dr Holzer’s vast experience in biomedical and genome research, including molecular biology and oncology, fits perfectly with our corporate focus,” says Pierre Dsy, the company’s president and CEO.

Dr Holzer holds a PhD in microbiology and immunology from the University of Illinois at Chicago. He has received several awards and has authored over 30 publications relative to his field. Prior to joining DiagnoCure, he was director of technology and development with the Whitehead Institute for Biomedical Research, at the Center for Genome Research in Cambridge, MA.

He will take full charge of the direction of DiagnoCure’s R&D efforts.